The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)
RFA-PS-19-001 

Grants.gov  https://www.grants.gov/web/grants/view-opportunity.html?oppId=308535

(optional)  Letter of Intent due: 12/14/2018

CDC solicitations are generally limited regarding the number of applications that may go forward in response to a specific solicitation. This is limited to one application per institution.

If you wish to apply to a program that limits the number of applications allowed per institution, please email a one-page abstract about your proposal with a link to the program of interest to Cheryl Ridgeway cheryl-a-ridgeway@uiowa.edu  in the Office of the Vice President for Research OVPR with a cc to the Division of Sponsored Programs  dsp@uiowa.edu  at least 30 days in advance of the deadline.  If we receive multiple abstracts in response to a given solicitation, a review will be conducted to select the applicant to submit on behalf of the University of Iowa.

The purpose of the research supported by this notice of funding opportunity (NOFO) is to develop feasible and effective models for using HIV point-of-care (POC) nucleic acid tests (NATs) to: (1) improve pre-exposure prophylaxis (PrEP) initiation, and duration of PrEP use, among persons at high-risk for acquiring HIV infection; and (2) reduce the time between testing in community-based and clinical-based settings and linkage to HIV care, anti-retroviral therapy (ART) initiation, and viral suppression.